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ApoE levels and chromosome 19 ApoE polymorphisms were measured in a sample
of 156 Dutch families. Each pedigree consisted of parents aged 35–65 years and
their twin offspring aged 14–21 years. A significant effect of the chromosome 19
apoE locus on quantitative plasma levels of apolipoprotein E was observed. The
ApoE polymorphism explained 16% of the variance in ApoE levels. Tests of
association of ApoE levels with the apoC1 locus, which is in complete linkage
disequilibrium with the ApoE locus, also showed a significant effect, although
the variance explained by ApoC1 was only 1%. Examination of the covariance
between twins classified according to allele sharing indicates that the association is
not due to population stratification, but to a genuine eff ct of the ApoE locus on
levels. However, the ApoE locus accounts for only one-fourth of the genetic varia-
tion in ApoE levels. Genet. Epidemiol. 18:331–340, 2000.© 2000 Wiley-Liss, Inc.
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INTRODUCTION
Apolipoprotein (Apo) E plays a central role in the metabolism of choles-
terol and triglycerides. It is one of the major protein constituents of chylomi-
crons, very low-density lipoprotein (VLDL), their remnant particles, and
high-density lipoprotein (HDL). On these particles, ApoE serves as a ligand for
the uptake by lipoprotein receptors [Havel et al., 1980; Sherril et al., 1980]. In
humans, ApoE is a polymorphic protein with three major isoforms, ApoE2, ApoE3,
and ApoE4 [Utermann et al., 1977]. In healthy individuals, between 5 and 15%
of normal interindividual variation in plasma cholesterol levels can be attributed
to this common ApoE polymorphism [Davignon et al., 1988]. In most human
populations it is found that individuals with ApoE2 display high levels of ApoE
and low levels of plasma cholesterol, low-density lipoprotein (LDL)-cholesterol
and ApoB whereas those with ApoE4 show the opposite [Davignon et al., 1988;
De Knijff et al., 1994b; Utermann, 1985]. Because of this influence of ApoE
phenotypes on circulating levels of lipids, the ApoE gene is often seen as a ma-
jor risk factor for atherosclerosis and coronary heart disease (CHD) [Luc et al.,
1994; Tiret et al., 1994; Hixson, 1991], although no increased risk for CHD among
ApoE4 carriers has been reported as well [Damaraju et al., 1995; De Knijff et
al., 1992]. For the most part, these ApoE effects can be attributed to a more
efficient catabolism of chylomicron remnants and intermediate density lipopro-
tein (IDL) particles in individuals with ApoE4 and a less efficient catabolism of
these particles in individuals with ApoE2, due to a defect in binding of ApoE2 to
hepatic lipoprotein receptors [Utermann, 1985, 1987; Weintraub et al., 1987]. In
addition, Weisgraber [1990] has shown that there is a marked difference in the
preference for the different lipoprotein particles between the common ApoE alle-
les, which could also explain part of differences in allelic influences of the com-
mon ApoE alleles. There is now evidence that in addition to differences in binding
efficiencies between the ApoE forms, the number of ApoE molecules on a lipo-
protein particle is also an important determinant of the clearance rate of these
particles. The more ApoE is present on a lipoprotein particle, the faster it will be
removed from the circulation [Dong et al., 1998]. It is, therefore, important to
understand which factors (ApoE genotypes, background genes and environments)
regulate the circulating levels of ApoE. Surprisingly few studies aimed at find-
ing answers for this question have been published [Moll, 1993].
In an earlier report, heritabilities of ApoE levels were estimated from a sample
of Dutch twins and their parents [Boomsma et al., 1996]. We found heritabilities
of 87% (twins) and 31% (parents) for circulating levels of ApoE. Smit et al.
[1988] demonstrated that in 35-year-old Dutch males about 18% of the variabil-
ity of circulating ApoE levels can be explained by the ApoE polymorphism. Oth-
ers have confirmed and refined these conclusions, indicating some interaction
with age and sex [Zerba et al., 1996]. With these estimates, we are still far from
any detailed insight. For example, it is still not known if the effect of the ApoE
polymorphism on levels of ApoE is due to dominant or additive effects of the
different alleles. Moreover, no studies to date show whether or not there are other
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genes that also influence ApoE levels [Moll, 1993]. In order to answer some of
these remaining questions, we report here the results of an analysis of the asso-




This study is part of a larger project in which cardiovascular risk factors were
studied in 160 adolescent twin pairs and their parents [Boomsma et al., 1993a,b,
1998; Kempen et al., 1991; de Knijff et al., 1994a]. Addresses of twins (between 14–
21 years of age) living in Amsterdam and neighboring cities were obtained from
City Council population registries. Twins living with both their biological parents
were contacted by letter. A family was included in the study if the twins and both
parents complied. In addition, a small number of families who heard of the study
from other twins also volunteered to participate. Zygosity was determined by blood
groups and DNA polymorphisms. Three series of triplets were included by discard-
ing the data from the second born child. There were 35 monozygotic female (MZF),
35 monozygotic male (MZM), 30 dizygotic female (DZF), 31 dizygotic male (DZM)
and 29 dizygotic opposite-sex pairs (DOS). Average age (with standard deviation in
parentheses) of fathers and mothers was 48.1 (6.3) and 45.6 (5.9) years, respectively,
and of the twins was: MZM, 16.57 (1.77); MZF, 16.04 (2.22); DZM, 17.16; (1.75);
DZF 17.66 (2.06); DOS 16.39 (1.82).
Measures
EDTA blood was obtained between 8:30 and 10:30 AM by venipuncture after
overnight fasting. Plasma was separated from cells after centrifugation for 10 min-
utes at 3,000 rpm. Part of the plasma was frozen at –20° ± °C for later use. ApoE
levels were quantified from the frozen samples by enzyme-linked immunosorbent
assays (ELISA) as described by Bury et al. [1986] . Blood samples were collected
over a 2-year period with on average 10 families coming to the laboratory on the
same occasion. ApoE levels were measured for all subjects simultaneously, with family
members randomly distributed over measurement batches. In these same subjects,
ApoE polymorphisms were assessed (ApoE isoforms E2, E3, and E4). ApoE pheno-
types were determined by isoelectric focusing of delapidated plasma samples fol-
lowed by immunoblotting as we have described previously [Havekes et al., 1987; De
Knijff et al., 1988]. In four families no ApoE data were available.
In the Dutch population, the ApoE polymorphism is in complete linkage dis-
equilibrium with a di-allelic Hpa1 polymorphism in the promotor region of the ApoC1
gene, 4.3 kb downstream of the ApoE gene [de Knijff, 1992; Smit et al., 1988]. The
ApoE2 isoform is linked to the ApoC1 Hpa1-2 (c1-2) allele, ApoE3 is linked to c1-
1, and ApoE4 is linked to c1-2. Hence, the six ApoE phenotypes can be replaced by
three ApoC1 genotypes (e2/e2 is c1-2/c1-2; e2/e3 is c1-2/c1-1; e3/e3 is c1-1/c1-1;
e2/e4 is c1-2/c1-2; e3/e4 is c1-1/c1-2 and e4/e4 is c1-2/c1-2). Assuming that this
disequilibrium is preserved in the sample being analyzed, it permits a test of the
effect of this di-allelic ApoC1 polymorphism on quantitative ApoE plasma levels, by
recoding the ApoE genotypes as ApoC1 genotypes.
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STATISTICAL METHODS
ApoE levels are known to vary with age and may vary with sex, so we devel-
oped a model for the influence of age, sex, and ApoE genotype on ApoE levels.
Residual variation not explained by these factors was modeled by partitioning varia-
tion into additive genetic, shared environment, and specific environment components.
Additive genetic factors give rise to a pattern of familial resemblance where MZ
twins correlate twice as much DZ twins who correlate the same as parents and off-
spring, with spouses uncorrelated. Shared environmental factors, here modeled as a
home environment, give rise to equal correlations for all relationships (spouses, par-
ent-offspring, MZ and DZ twin). Specific environment factors, including error of
measurement, make individuals different from their relatives. A path diagram of the
model is shown in Figure 1. It is the job of model fitting to find the combination of
these components that best matches the observed pattern of familial resemblance in
the data.
Modeling the ApoE level for individuals requires the computation of a pre-
dicted level that may vary for each subject, according to their age, sex, and ApoE
Fig. 1. Path diagram showing familial resemblance for ApoE levels as a function of additive genetic
(a), shared (c), and non-shared environment (e) effects. In addition to these sources of variation, indi-
vidual means are modeled as a function of ApoE genotype, age, and sex.
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genotype. Using special features of the Mx [Neale, 1997], known as definition vari-
ables [Neale, 1998], we specified a model for the mean of subject i as
µi = µ + Ageiµa + Sexiµs + µgi
where for subject i: Age i is their age at observation; Sex i is their sex coded as 0 for
females and 1 for males; a and s are the age and (male) sex deviations; and gi is the
mean of genotype i. For the ApoE locus, six genotypes are recognized: e2/e2; e2/e3;
e3/e3; e2/e4; e3/e4; and e4/e4. Comparison of parameter estimates and goodness of
fit indices when age, sex, or genotypic effects are not included in the model allows
estimation of the statistical significance of these effects via log-likelihood ratio tests.
Mx scripts for these models and the raw data are available on the Mx website http://
views.vcu.edu/mx. The method assumes multivariate normality of the data condi-
tional on the particular age, sex, and genotype of the individual. That is, multivari-
ate normality of the residuals is assumed, rather than of the raw distribution. Skewness
and kurtosis of these residuals are small, and simulations have shown that the likeli-
hood method is fairly robust to violations of this assumption [Allison et al., 1999].
It should be noted that mean differences in ApoE levels as a function of geno-
type could occur from either functional effects of the ApoE locus itself, or from a
nearby locus in linkage disequilibrium (LD) with it, or artifactually through, e.g.,
population stratification [Fulker et al., 1998; Neale et al., 1999]. To examine whether
the ApoC1 locus might be affecting levels, we constrained the means to be equal for
ApoE phenotypes e2/e2, e2/e4, and e4/e4 (c1-2/c1-2), and for e2/e3 and e3/e4 (c1-1/
c1-2), which, together with e3/e3 (c1-1/c1-1), results in only three ApoC1 genotypic
means for additive and non-additive effects at this di-allelic locus. To test for pos-
sible stratification effects, we considered the sibling (DZ) intrapair similarity as a
function of sharing alleles identical by state.
RESULTS
Table I gives an overview of the distribution of observed ApoE isoforms sepa-
rately for parents (father and mother) and first- and second-born twins. There is a
pronounced asymmetry in the genotypic frequencies: alleles 2 and 4 are relatively
rare. This asymmetric distribution is in accordance with theory and observation of
other polymorphic loci which typically display a Dirichlet-multinomial distribution
of allele frequencies [Weir, 1996; Lange, 1995]. The net effect is that there is scant
information on the means for genotypes 2=2; 4=4 and 4=2, while the other geno-
types have quite large sample sizes.
TABLE I. Frequency Distribution of ApoE Isoforms
Isoforms Father Mother Twin1 Twin2
2/2 2 1 0 1
3/2 21 26 32 29
3/3 86 94 81 85
4/3 42 25 36 38
4/4 3 2 3 3
4/2 2 8 4 0
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Mean ApoE levels of the more frequent genotypes (Table II) follow the pattern
of 3/2 > 3/3 > 4/3 consistently for fathers, mothers and both twins. The relatively
small differences between fathers and mothers suggest that gender plays a minor
role in ApoE levels, though the data should be corrected for age, which is properly
accomplished with model-fitting. Results of model fitting are presented in Table III.
The first, saturated model estimates the overall population mean at 6.5 with an incre-
ment of .03 per year of age.
The estimate of µs is –.67 suggesting a lower mean of males. The estimated
mean parameters for 3/2, 3/3, and 4/3 agree with the observed pattern in the data
shown in Table I, and indicate approximately 2.4 difference between those with 3/2
and those with 4/3 genotypes. Residual variation appears largely (71%) genetic with
no effect of shared family environment. In Model II, the sex difference is eliminated,
but doing so causes a significant loss of fit, as seen in the ∆χ2. Model III tests the
age increment, which is also found to be highly significant. Model IV eliminates the
effects of the ApoE locus, which again produces a highly significant loss of fit, indi-
cating that the ApoE locus accounts for a significant proportion of variation in ApoE
levels.
Model V, which attempts to explain variation in ApoE levels by equating the
parameters according to the most likely ApoC1 genotypes based on LD, does not
produce a significantly better fit than Model IV (∆χ22 = 0:88). This result supports
the hypothesis that ApoE levels are controlled by the ApoE locus rather than the
Hpa1 site in the promotor region of than the ApoC1 locus. The effects of age, sex,
and genotype are therefore all highly significant and are required for a parsimonious
explanation of the data.
The maximum likelihood estimate of the ApoE level variance, δ2 varies ac-
cording to which model is fitted. It is lowest for Model I because the model for
the means takes into account the effects of age, sex, and genotype, which in turn
leaves less variance to explain. From these estimates it is possible to assess the
proportion of variance accounted for by the difference sources. ApoE genotype
accounts for (6.68–5.62)/6.68=15.9% of the variance. In contrast, ApoC1 accounts
for (6.68–6.62)/6.68=0.8% of the variance, and yields a substantially poorer fit
to the data.
Estimates of the proportion of variance accounted for by residual additive ge-
netic factors, α2, are approximately .70 for models in which the effect of the ApoE
locus are included, and are .81 when it is omitted. These results suggest that there is
substantial genetic variation not accounted for by the ApoE polymorphisms nor by
TABLE II. Mean ApoE Levels for the apoE Isoforms
Fathers Mothers Twin1 Twin2
Group Mean SD Mean SD Mean SD Mean SD
2/2 11.50 5.36 17.75 — — — 7.20 —
3/2 9.43 1.62 10.04 2.84 9.67 2.47 9.17 2.84
3/3 7.57 2.23 7.51 2.39 6.50 1.70 6.46 1.71
4/3 6.95 2.19 6.58 2.10 5.46 1.71 5.45 1.67
4/4 6.14 2.78 4.07 0.68 4.20 1.20 5.66 3.80
4/2 9.47 .43 9.98 2.54 9.38 1.89 — —
Total 7.71 2.34 7.93 2.81 6.94 2.43 6.71 2.34
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loci in linkage disequilibrium with the ApoE locus. This impression is confirmed by
Model VI, which fixes the residual genetic variance at zero; doing so results in a
substantial loss of fit (∆χ2 = 34.87).
To test for the effects of non-additivity in the genotypic effects, the model was
parameterized in terms of two allele deviations µ3 and µ4 for the e3 and e4 alleles,
respectively, while the deviation µ2 for the e2 allele was fixed at zero. Model VII
shows the results of fitting this model; estimates of the allele means were µ3 = 1.47
and µ4 = 2.27. The loss of fit of this model compared to Model I is not statistically
significant, which suggests that genetic dominance at the ApoE locus is either small
or non-existent.
To investigate possible stratification, we grouped the DZ twins in the sample
according to the number of alleles that they shared identical by state (IBS) at the
ApoE locus. There were 127 pairs sharing two alleles IBS, 33 pairs sharing one
allele, and no pairs sharing zero alleles IBS, a pattern that is not unexpected
given the unequal allele frequencies at this locus. The correlation for ApoE level
between siblings sharing two alleles IBS is .809 (P< .0001) and between siblings
sharing 1 allele IBS it is -0.011 (P = .95). The difference between these correla-
tions is highly significant (χ2 = 29.7, df = 1, P < .0001). These results support
the hypothesis of an allele effect at the ApoE locus, rather than population strati-
fication. Pure stratification would act like a shared environment and generate
approximately equal correlations for the two groups.
TABLE III. Parameters Estimates and Goodness of Fit Statistics for a Variety of Models and
Submodels Applied to the Twin-Family ApoE Genotype and Phenotype Data*
Model
Parameter I II III IV V VI VII
m 6.50 (6.01; 6.99) 6.26 7.74 6.64 6.55 6.46 9.45
ma 0.03 (0.02; 0.04) 0.03 [0.00] 0.03 0.03 0.03 0.03
ms –0.67 (–1.05; –0.30) [0.00] –0.55 –0.82 –0.84 –0.60 –0.69
m2/2 0.86 (–1.60; 3.33) 0.71 1.42 [0.00] 0.08† 2.84 0.00
m3/2 1.49 (0.93; 2.04) 1.45 1.36 [0.00] 0.21‡ 1.84 –1.47
m3/3 0.00 (0.00; 0.00) [0.00] [0.00] [0.00] 0.00 0.00 –2.94
m4/3 –0.87 (–1.39; –0.35) –1.06 –1.21 [0.00] 0.21‡ –0.94 –3.74
m4/4 –1.64 (–3.17; –0.11) –1.85 –2.02 [0.00] 0.08† –1.81 –4.54
m4/2 2.02 (0.24; 3.80) 1.96 1.66 [0.00] 0.08† 2.07 –2.27
a2 0.71 (0.52; 0.84) 0.70 0.59 0.81 0.81 [0.00] 0.68
c2 0.00 (0.00; 0.08) 0.00 0.00 0.00 0.00 0.20 0.00
e2 0.29 (0.16; 0.46) 0.30 0.41 0.19 0.19 0.80 0.32
ŝ 2 5.62 (4.87; 6.58) 5.70 5.68 6.68 6.62 5.13 5.56
∆χ2 12.39 48.65 53.90 53.02 34.87 5.93
df 1 1 5 3 1 3
p 0.00 0.00 0.0 0.00 0.00 .12
*∆c2 denotes the difference in fit against the first model. The parameters are: m, the global mean; ma,
the age deviation; ms, the sex deviation; mi/j, the deviation specific for individuals with genotype i/j; a2,
c2 and e2 are the proportions of vartiance associated with additive genetic, common environment and
specific environment sources, respectively; and ŝ is the total background variance from these sources.
Parameters fixed ex hypothesi are denoted by brackets.
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CONCLUSION
The aims of this article were to increase understanding about the relationship
between polymorphisms at the ApoE locus and ApoE levels in the blood. These aims
were achieved by developing a statistical model for the effects of age, sex, and ApoE
genotype on circulating levels of ApoE. Several variants of the model were fitted to
data collected from Dutch twins and their parents.
One clear result is that there is significant familial resemblance that is not ac-
counted for by variation at the ApoE locus. This residual resemblance appears to be
genetic rather than environmental in origin, and may be responsible for more than
50% of variance in ApoE levels (non-ApoE genotype variance is 84% and this varia-
tion has 70% heritability; .7*.84 = .59). These results would appear to justify a ge-
nome scan for other loci that may determine ApoE levels. It is possible that some of
the residual genetic variation is behaviorally mediated via pathways such as dietary
preference. However, complex behavioral phenotypes may be less likely to be influ-
enced by loci of large effect.
A large and robust effect of the ApoE locus on ApoE levels was found. The 4/4
genotype has the lowest and the 4/2 genotype has highest sample mean. The confi-
dence intervals on the genotypic means vary quite markedly because the sample size
differs substantially across genotypes. There is no evidence for genetical dominance
of the alleles at the ApoE locus; genetic variation at the ApoE locus appears additive.
This may suggest that ApoE levels have not been under selective pressure in the
evolutionary history of mankind [Fisher, 1929].
We explored the extent to which variation in ApoE levels might be accounted
for by the ApoC1 locus, which is in strong linkage disequilibrium with ApoE in the
Dutch population. Variation in ApoE levels does not appear to be associated with the
diallelic ApoC1 genotype. These results suggest that, despite the fact that this diallelic
polymorphism appears to be in complete LD with, and only 4.3 kb downstream from,
a major gene (ApoE), it would not have been detected in an association analysis
using ApoC1 genotypes. This finding is consonant with recent reports of difficulties
using single-nucleotide polymorphisms (SNPs) to detect disease-related genes and
quantitative trait loci for LDL [Nickerson et al., 1998; Pennisi, 1998]. In part this
may be due to the ApoC locus being less informative. It also remains possible that
the complete LD observed in other Dutch samples is not preserved here; only direct
assessment of the ApoC locus in this sample could resolve this question. Nonethe-
less, caution would seem to be required when trying to exclude regions based on
genome-wide association studies, as nearby loci in substantial LD can have quite
large effects.
The association with the ApoE locus does not appear to be an effect of popula-
tion stratification. DZ twin pairs were classified as sharing either one or two alleles
identical by state at the ApoE locus; no pairs shared zero alleles. Pairs sharing two
alleles IBS showed remarkable similarity in ApoE level, correlating .81, whereas
those sharing one allele were essentially uncorrelated. A more sophisticated parti-
tioning of variance into within and between family components of the association,
such as that proposed by Fulker et al. [1998] and Neale et al. [1999] might be used
to explore this finding further.
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